mestranol has been researched along with medroxyprogesterone acetate in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Russo, IH; Russo, J | 1 |
| Shubik, P | 1 |
| Bloch, E; Varma, SK | 1 |
| Insler, V; Kleinman, D; Sarov, I | 1 |
| Burket, RL; Rauh, JL; Waldrop, CD | 1 |
| Arntzenius, AC; Havekes, L; Hessel, LW; Stegerhoek, CI; van Gent, CM | 1 |
| Fujimaki, T; Kurabayashi, T; Oda, K; Tanaka, K; Yamamoto, Y; Yasuda, M | 1 |
| Felix, JC; Moyer, DL | 1 |
| Cromie, MA; Maile, MH; Wajszczuk, CP | 1 |
| Garceau, RJ; Kaunitz, AM; Wajszczuk, CJ | 1 |
| Applezweig, N | 1 |
| Bonte, J; Ide, P; Wijnants, P | 1 |
| Koffel, JC | 1 |
| Kistner, RW | 1 |
| Beck, P; Hoff, DL; Venable, RL | 1 |
| Prous, JR; Sussmann, AR | 1 |
| Ojo, OA; Wien, EM | 1 |
| Aberg, J; Aweeka, FT; Bardeguez, A; Coombs, RW; Lizak, P; Rosenkranz, SL; Segal, Y; Thevanayagam, L; Watts, DH | 1 |
4 trial(s) available for mestranol and medroxyprogesterone acetate
| Article | Year |
|---|---|
Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigator
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Lipids; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Triglycerides | 2000 |
Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Patient Compliance; Uterine Hemorrhage | 2000 |
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin | 2003 |
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Reverse Transcriptase Inhibitors; RNA, Viral; Sex Factors; Viral Load; Zidovudine | 2006 |
20 other study(ies) available for mestranol and medroxyprogesterone acetate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Progestagens and mammary gland development: differentiation versus carcinogenesis.
Topics: Animals; Cell Differentiation; Cell Division; Chorionic Gonadotropin; DNA; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Norethynodrel; Ovariectomy; Placental Lactogen; Progestins; Rats; Rats, Inbred Strains | 1991 |
Oral contraceptives and breast cancer: laboratory evidence.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Dogs; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Mice; Norethindrone; Norethynodrel; Rats | 1985 |
Effects of prenatal administration of mestranol and two progestins on testosterone synthesis and reproductive tract development in male rats.
Topics: Animals; Ethinyl Estradiol; Female; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Organ Size; Placenta; Pregnancy; Prostate; Rats; Rats, Inbred Strains; Seminal Vesicles; Testis; Testosterone | 1987 |
The effects of contraceptive hormones on the replication of Chlamydia trachomatis in human endometrial cells.
Topics: Chlamydia Infections; Chlamydia trachomatis; Endometrium; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Time Factors | 1987 |
Chromosomally competent ovarian failure at adolescence.
Topics: Adolescent; Contraceptives, Oral, Combined; Diagnosis, Differential; Drug Combinations; Estrogens, Conjugated (USP); Female; Gonadal Dysgenesis; Humans; Karyotyping; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause, Premature; Menstruation Disturbances; Mestranol; Norethindrone; Norethynodrel; Ovarian Function Tests; Ovary; Turner Syndrome | 1983 |
High density lipoprotein cholesterol and apolipoprotein A-I levels in 32-33-year-old women on steroid contraceptives-differences between two frequently used low-estrogen pills.
Topics: Adult; Alcohol Drinking; Apolipoprotein A-I; Apolipoproteins; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Lynestrenol; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Smoking | 1981 |
Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte subsets in premature ovarian failure and Turner's syndrome.
Topics: Absorptiometry, Photon; Adult; Bone Density; Estrogen Replacement Therapy; Female; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Mestranol; Primary Ovarian Insufficiency; T-Lymphocyte Subsets; Turner Syndrome | 1993 |
The effects of progesterone and progestins on endometrial proliferation.
Topics: Atrophy; Biopsy; Cell Division; Contraceptives, Oral; Cyclins; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Mitosis; Norethindrone; Norethindrone Acetate; Norethynodrel; Postmenopause; Premenopause; Progesterone Congeners; Proliferating Cell Nuclear Antigen; Stromal Cells | 1998 |
Steroids.
Topics: Adrenal Cortex Hormones; Africa; Americas; Asia; Biology; Chlormadinone Acetate; Contraception; Contraceptives, Oral; Developed Countries; Developing Countries; Dimethisterone; Economics; Endocrine System; Estradiol; Ethynodiol Diacetate; Europe; Europe, Eastern; Family Planning Services; Germany, West; Hormones; Italy; Latin America; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Mexico; Netherlands; Norethindrone; Norethynodrel; Norgestrel; North America; Physiology; Progesterone; Progestins; Research; Switzerland; Technology; Testosterone; United Kingdom; United States | 1969 |
[Cytologic observations of cervicovaginal smears during hormonal contraception].
Topics: Age Factors; Belgium; Biology; Birth Rate; Cells; Cervix Uteri; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Developed Countries; Disease; Europe; Family Planning Services; Fertility; Genitalia; Genitalia, Female; Lynestrenol; Medroxyprogesterone Acetate; Mestranol; Neoplasms; Parity; Physiology; Population; Population Characteristics; Population Dynamics; Prospective Studies; Research; Urogenital System; Uterine Cervical Neoplasms; Uterus; Vagina; Vaginitis | 1972 |
[Pills and minipills].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Disease; Estrogens; Ethinyl Estradiol; Family Planning Services; Injections; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Mestranol; Progesterone Congeners | 1978 |
Newer synthetic progestins for the treatment of endometriosis.
Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Digestive System; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Injections; Lynestrenol; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Mestranol; Metrorrhagia; Nausea; Norethindrone; Norethynodrel; Pseudopregnancy; Reproduction; Signs and Symptoms; Thromboembolism; Vascular Diseases | 1970 |
Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives.
Topics: Animals, Laboratory; Biology; Carbohydrates; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Diagnosis; Ethinyl Estradiol; Family Planning Services; Glucose; Glucose Tolerance Test; Medroxyprogesterone Acetate; Mestranol; Metabolism; Norethindrone; Physiology; Research | 1975 |
[Gas chromatography of oral progestagens and estrogens].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Dimethisterone; Ethinyl Estradiol; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Norethindrone; Norgestrel | 1968 |
Serum vitamin A, carotene and cholesterol levels in Nigerian women using various types of contraceptives.
Topics: Africa; Africa South of the Sahara; Africa, Western; Age Factors; Biology; Body Weight; Clinical Laboratory Techniques; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Developing Countries; Educational Status; Ethinyl Estradiol; Family Planning Services; Health; Hematocrit; Injections; Intrauterine Devices; Intrauterine Devices, Copper; Lipids; Medroxyprogesterone Acetate; Mestranol; Nigeria; Norethynodrel; Nutritional Physiological Phenomena; Parity; Physiology; Population Characteristics; Vitamin A; Vitamins | 1982 |